Akeso, Inc. Completes Patient Enrollment in Global Phase III Trial Evaluating Ivonescimab for First-Line Treatment of Squamous NSCLC

 Akeso, Inc. (9926.HK) ("Akeso" or the "Company")  is excited to announce the completion of patient enrollment in the global Phase III clini...

February 06, 2025 | Thursday | News
Akeso’s Cadonilimab Combination Therapy Shows Landmark Survival Benefits in Advanced Gastric Cancer, Published in Nature Medicine

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine published the results of ...

January 23, 2025 | Thursday | News
Fermion and Simcere Partner to Advance Innovative SSTR4 Agonist for Pain Management in Greater China

Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain ...

January 20, 2025 | Monday | News
Vertex Pharmaceuticals and Zai Lab Announce Exclusive Collaboration for Development and Commercialization of Povetacicept in Asia

-Vertex Pharmaceuticals Incorporated  and Zai Lab Limited announced an exclusive collaboration and license agreement for the development a...

January 13, 2025 | Monday | News
Eyebright Medical’s Loong Crystal PR Intraocular Lens Receives NMPA Class III Medical Device Certification

Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collective...

January 08, 2025 | Wednesday | News
HUTCHMED and AstraZeneca's ORPATHYS® + TAGRISSO® Combo for MET-Driven NSCLC Granted Priority Review by China’s NMPA

HUTCHMED (China) announces that the New Drug Application (“NDA”) for the combination of ORPATHYS® (savolitinib) and TAGRISSO&re...

January 02, 2025 | Thursday | News
CARsgen Therapeutics Launches Investigator-Initiated Trial in China for KJ-C2219, an Allogeneic CAR T-Cell Therapy Targeting CD19/CD20

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...

January 01, 2025 | Wednesday | News
HKBU and Shanghai Sixth People's Hospital Pioneer Breakthrough Treatment for Rare Bone Disease XLH

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao ...

December 23, 2024 | Monday | News
Duality Biologics Signs Exclusive Option Agreement with GSK for ADC Candidate DB-1324 in Gastrointestinal Cancer

 Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjuga...

December 04, 2024 | Wednesday | News
Merck’s Sacituzumab Tirumotecan Receives FDA Breakthrough Therapy Designation for Advanced EGFR-Mutated NSCLC

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthroug...

December 04, 2024 | Wednesday | News
Red Ginseng Shown to Boost Bone and Intestinal Health, Michigan State Study Reveals

Professor Narayanan Parameswaran's team at the Department of Physiology at Michigan State University announced the results of a study that s...

November 12, 2024 | Tuesday | News
Akeso Biopharma Initiates Phase III Study for Ivonescimab in Advanced Biliary Tract Cancer

Akeso Biopharma (9926.HK) is pleased to announce the successful enrollment of the first patient in the HARMONi-GI-01/AK112-309 study, a randomized, control...

November 01, 2024 | Friday | News
Antengene Secures South Korean Approval for XPOVIO® in Combination Therapy for Multiple Myeloma

SHANGHAI and HONG KONG, Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmac...

October 18, 2024 | Friday | News
Nuance Pharma Expands Bentrio® Nasal Spray Reach Across East and South East Asia

Altamira Therapeutics announces the extension of its exclusive license with Nuance Pharma to cover Singapore, Malaysia, Thailand, Philippines, Indonesia,...

September 17, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close